loadpatents
name:-0.038733005523682
name:-0.014413833618164
name:-0.0026838779449463
RUNDFELDT; Chris Patent Filings

RUNDFELDT; Chris

Patent Applications and Registrations

Patent applications and USPTO patent grants for RUNDFELDT; Chris.The latest application filed is for "therapeutic combinations, liquid pharmaceutical compositions, kits for their preparation, and methods of their use".

Company Profile
2.14.38
  • RUNDFELDT; Chris - Coswig DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Therapeutic Combinations, Liquid Pharmaceutical Compositions, Kits For Their Preparation, And Methods Of Their Use
App 20220193028 - RUNDFELDT; Chris
2022-06-23
Pharmaceutical Composition Containing Dimethyl Fumarate For Administration At A Low Daily Dose
App 20220168255 - Galetzka; Christin ;   et al.
2022-06-02
Pharmaceutical Composition Containing Dimethyl Fumarate For Administration At A Low Daily Dose
App 20210290582 - Galetzka; Christin ;   et al.
2021-09-23
Pharmaceutical Composition Containing Dimethyl Fumarate For Administration At A Low Daily Dose
App 20190201369 - GALETZKA; Christin ;   et al.
2019-07-04
Pharmaceutical Composition Containing Dimethyl Fumarate For Administration At A Low Daily Dose
App 20190125711 - GALETZKA; Christin ;   et al.
2019-05-02
Pharmaceutical Composition Containing Dimethyl Fumarate For Administration At A Low Daily Dose
App 20180338946 - GALETZKA; Christin ;   et al.
2018-11-29
Pharmaceutical Composition Containing Dimethyl Fumarate For Administration At A Low Daily Dose
App 20180256530 - GALETZKA; Christin ;   et al.
2018-09-13
Pharmaceutical Composition Containing Dimethyl Fumarate For Administration At A Low Daily Dose
App 20180092875 - GALETZKA; Christin ;   et al.
2018-04-05
Pharmaceutical Composition Containing Dimethyl Fumarate For Administration At A Low Daily Dose
App 20180021289 - GALETZKA; Christin ;   et al.
2018-01-25
Pharmaceutical Composition Containing Dimethyl Fumarate For Administration At A Low Daily Dose
App 20170231943 - GALETZKA; Christin ;   et al.
2017-08-17
Use Of Dihydroimidazolones For The Treatment Of Dogs
App 20160367562 - RUNDFELDT; Chris ;   et al.
2016-12-22
Use of dihydroimidazolones for the treatment of dogs
Grant 9,469,611 - Rundfeldt , et al. October 18, 2
2016-10-18
Pharmaceutical Composition Containing Dimethyl Fumarate For Administration At A Low Daily Dose
App 20160206586 - GALETZKA; Christin ;   et al.
2016-07-21
Pharmaceutical Composition Containing Dimethyl Fumarate For Administration At A Low Daily Dose
App 20160206587 - GALETZKA; Christin ;   et al.
2016-07-21
Use Of Dihydroimidazolones For The Treatment Of Dogs
App 20150072983 - RUNDFELDT; Chris ;   et al.
2015-03-12
Use of dihydroimidazolones for the treatment of dogs
Grant 8,962,617 - Rundfeldt , et al. February 24, 2
2015-02-24
Use of dihydroimidazolones for the treatment of dogs
Grant 8,859,540 - Rundfeldt , et al. October 14, 2
2014-10-14
Use Of Dihydroimidazolones For The Treatment Of Dogs
App 20130065898 - RUNDFELDT; CHRIS ;   et al.
2013-03-14
Nanosuspension With Antifungal Medication To Be Administered Via Inhalation With Improved Impurity Profile And Safety
App 20110190245 - Rundfeldt; Chris ;   et al.
2011-08-04
7-azaindoles and the use thereof as therapeutic agents
Grant 7,947,705 - Hofgen , et al. May 24, 2
2011-05-24
Potassium Channel Activators for the Prevention and Treatment of Dystonia and Dystonia Like Symptoms
App 20090318507 - Rundfeldt; Chris ;   et al.
2009-12-24
Pyrido[3,2-e]pyrazines, their use as inhibitors of phospohodiesterase 10, and processes for preparing them
App 20090239874 - Hofgen; Norbert ;   et al.
2009-09-24
Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
Grant 7,550,465 - Hofgen , et al. June 23, 2
2009-06-23
Methods of Treating Obesity and Metabolic Disorders
App 20090143392 - Hofgen; Norbert ;   et al.
2009-06-04
Potassium Channel Activators for the Prevention and Treatment of Dystonia and Dystonia-Like Symptoms
App 20090137641 - Rundfeldt; Chris ;   et al.
2009-05-28
Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
App 20080114032 - Langen; Barbara ;   et al.
2008-05-15
R-(+)-alpha-liponic acid for the prevention of diabetes
App 20080095741 - Wessel; Klaus ;   et al.
2008-04-24
Use of dihydroimidazolones for the treatment of dogs
App 20080027057 - Rundfeldt; Chris ;   et al.
2008-01-31
Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
App 20080027064 - Hofgen; Norbert ;   et al.
2008-01-31
Use of the non-opiate analgesic drug flupirtine for the treatment of overactive bladder and associated diseases including urge incontinence, urinary flow problems as a result of prostate hyperplasia and irritable bowel syndrome
Grant 7,309,713 - Rundfeldt , et al. December 18, 2
2007-12-18
7-Azaindoles and the use thereof as therapeutic agents
App 20070161671 - Hofgen; Nobert ;   et al.
2007-07-12
7-azaindoles and the use thereof as therapeutic agents
Grant 7,211,583 - Hofgen , et al. May 1, 2
2007-05-01
Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
App 20070093531 - Hofgen; Norbert ;   et al.
2007-04-26
Hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
Grant 7,166,637 - Hofgen , et al. January 23, 2
2007-01-23
Use of the non-opiate analgesic drug flupirtine of the treatment of overactive bladder and associated diseases including urge incontinence, urinary flow problems as a result of prostate hyperplasia and irritable bowl syndrome
App 20060173052 - Rundfeldt; Chris ;   et al.
2006-08-03
4-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents
Grant 7,067,536 - Hofgen , et al. June 27, 2
2006-06-27
4-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents
App 20060128758 - Hofgen; Nobert ;   et al.
2006-06-15
Use of dihydroimidazolones for the treatment of dogs
App 20050070537 - Rundfeldt, Chris ;   et al.
2005-03-31
Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
App 20050032863 - Langen, Barbara ;   et al.
2005-02-10
5-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents
App 20040266760 - Hofgen, Nobert ;   et al.
2004-12-30
4-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents
App 20040242643 - Hofgen, Nobert ;   et al.
2004-12-02
7-azaindoles and the use thereof as therapeutic agents
App 20040224971 - Hofgen, Nobert ;   et al.
2004-11-11
Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
App 20040147759 - Hofgen, Norbert ;   et al.
2004-07-29
Treatment of nonallergic rhinitis by selective phosphodiesterase 4 inhibitors
App 20040116501 - Rundfeldt, Chris ;   et al.
2004-06-17
Topical treatment of skin diseases
App 20040038958 - Rundfeldt, Chris ;   et al.
2004-02-26
2,5-Dihydro-pyrazolo[3,4-d]pyrimidin-4-ones with an anticonsulsive action and methods for producing the same
App 20030186997 - Arnold, Thomas ;   et al.
2003-10-02
For a process for treatment of anxiety and tension
Grant 5,994,347 - Rostock , et al. November 30, 1
1999-11-30
Use of 2-4-amino-4-(4-fluorobenzylamino) (-1-ethoxy-carbonylaminobenzene for the prophylaxis and treatment of the neurodegenerative disorders
Grant 5,852,053 - Rostock , et al. December 22, 1
1998-12-22
Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for the prophylaxis and treatment of reduced cerebral blood supply
Grant 5,849,789 - Rostock , et al. December 15, 1
1998-12-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed